Smartleaf Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.7K Hold
1,208
﹤0.01% 1701
2026
Q1
$34.1K Buy
1,208
+62
+5% +$2.12K ﹤0.01% 1671
2025
Q4
$46K Buy
1,146
+429
+60% +$15.7K ﹤0.01% 1596
2025
Q3
$25K Buy
717
+237
+49% +$8.17K ﹤0.01% 1719
2025
Q2
$15.5K Sell
480
-425
-47% -$13.8K ﹤0.01% 1660
2025
Q1
$28.8K Buy
905
+143
+19% +$5.31K ﹤0.01% 1422
2024
Q4
$23.1K Buy
762
+385
+102% +$12.4K ﹤0.01% 1570
2024
Q3
$10.6K Buy
377
+317
+528% +$7.81K ﹤0.01% 1715
2024
Q2
$1.4K Buy
+60
New +$1.39K ﹤0.01% 2334

Other funds holding ATRC

Smartleaf Asset Management's ATRC Position: Q2 2026 in Review

Smartleaf Asset Management held its AtriCure (ATRC) position steady in Q2 2026 at 1,208 shares worth $34.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1701.

Smartleaf Asset Management first reported a position in ATRC in Q2 2024 and has held it in 9 quarters since. The position peaked at $46K in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Smartleaf Asset Management held 1,208 shares of AtriCure worth $34.7K as of Q2 2026.
  • Smartleaf Asset Management left its AtriCure share count unchanged in Q2 2026.
  • AtriCure made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1701 holding.
  • Smartleaf Asset Management first reported a position in AtriCure in Q2 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's AtriCure position peaked at $46K in Q4 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.